Phage P1-Derived Artificial Chromosomes Facilitate Heterologous Expression of the FK506 Gene Cluster

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Jones, Adam C ^a   Gust, Bertolt ^a   Kulik, Andreas ^a   Heide, Lutz ^a   Buttner, Mark J ^b   Bibb, Mervyn J ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCOMYCIN; TACROLIMUS;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIOPHAGE P1 ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; DNA MODIFICATION; DRUG CONJUGATION; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; FK506 GENE; FKBN GENE; GENE CLUSTER; GENE OVEREXPRESSION; GENE TRANSFER; HETEROLOGOUS EXPRESSION; MOLECULAR CLONING; MOLECULAR LIBRARY; NONHUMAN; REGULATOR GENE; STREPTOMYCES COELICOLOR; STREPTOMYCES TSUKUBAENSIS;

BACTERIOPHAGES; CHROMOSOMES, ARTIFICIAL, P1 BACTERIOPHAGE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; IMMUNOSUPPRESSIVE AGENTS; MULTIGENE FAMILY; STREPTOMYCES; TACROLIMUS;

EID: 84880075289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069319     Document Type: Article

References (54)

1. Medini D, Serruto D, Parkhill J, Relman DA, Donati C, et al. (2008) Microbiology in the post-genomic era. Nat Rev Microbiol 6: 419-430.
2. Kim CG, Lamichhane J, Song KI, Nguyen VD, Kim DH, et al. (2008) Biosynthesis of rubradirin as an ansamycin antibiotic from Streptomyces achromogenes var. rubradiris NRRL3061. Arch Microbiol 189: 463-473.
3. Laureti L, Song L, Huang S, Corre C, Leblond P, et al. (2011) Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci USA 108: 6258-6263.
4. Flinspach K, Westrich L, Kaysser L, Siebenberg S, Gomez-Escribano JP, et al. (2010) Heterologous expression of the biosynthetic gene clusters of coumermycin A1, chlorobiocin and caprazamycins in genetically modified Streptomyces coelicolor strains. Biopolymers 93: 823-832.
5. Gomez-Escribano JP, Bibb MJ, (2011) Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb Biotechnol 4: 207-215.
6. Komatsu M, Komatsu K, Koiwai H, Yamada Y, Kozone I,et al. (2013) Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites. ACS Synth Biol. doi:10.1021/sb3001003.
7. Gust B, (2009) Cloning and analysis of natural product pathways. Meth Enzymol 458: 159-180.
8. Kim EJ, Lee JH, Choi H, Pereira AR, Ban YH, et al. (2012) Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product. Org Lett 14: 5824-5827.
9. Dangel V, Härle J, Goerke C, Wolz C, Gust B, et al. (2009) Transcriptional regulation of the novobiocin biosynthetic gene cluster. Microbiol 155: 4025-4035.
10. Eustáquio AS, Gust B, Galm U, Li S-M, Chater KF, et al. (2005) Heterologous expression of novobiocin and chlorobiocin biosynthetic gene clusters. Appl Environ Microbiol 71: 2452-2459.
11. Banik JJ, Brady SF, (2010) Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr Opin Microbiol 13: 603-609.
12. Kim JH, Feng Z, Bauer JD, Kallifidas D, Calle PY, et al. (2010) Cloning large natural product gene clusters from the environment: Piecing environmental DNA gene clusters back together with TAR. Biopolymers 93: 833-844.
13. Heide L, (2009) Aminocoumarins: Mutasynthesis, chemoenzymatic synthesis, and metabolic engineering. Methods Enzymol 459: 437-455.
14. Binz TM, Wenzel SC, Apotheke H-JS, Bechthold A, Müller R, (2008) Heterologous expression and genetic engineering of the phenalinolactone biosynthetic gene cluster by using Red/ET recombineering. ChemBioChem 9: 447-454.
15. Kouprina N, Larionov V, (2008) Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae. Nat Protocols 3: 371-377.
16. Sosio M, Giusino F, Cappellano C, Bossi E, Puglia AM, et al. (2000) Artificial chromosomes for antibiotic-producing actinomycetes. Nat Biotechnol 18: 343-345.
17. Gomez-Escribano JP, Bibb MJ, (2012) Streptomyces coelicolor as an expression host for heterologous gene clusters. Methods Enzymol 517: 279-300.
18. Miao V, Coëffet-LeGal M-F, Brian P, Brost R, Penn J, et al. (2005) Daptomycin biosynthesis in Streptomyces roseosporus: Cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiol 151: 1507-1523.
19. Kino T, Hatanka H, Hashimoto M, Nishiyama M, Goto T, et al. (1987) FK-506, a novel immunosuppressant isolated from Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40: 1249-1255.
20. Martínez-Castro M, Salehi-Najafabadi Z, Romero F, Pérez-Sanchiz R, Fernández-Chimeno RI, et al. (2013) Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. Appl Microbiol Biotechnol 97: 2139-2152.
21. Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, et al. (1997) Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 20: 257-260.
22. Dumont FJ, (2000) FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem 7: 731-748.
23. Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, et al. (2006) Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 6(5 Pt.2): 1111-1131.
24. Michel G, Kemeny L, Homey B, Ruzicka T, (1996) FK506 in the treatment of inflammatory skin disease: Promises and perspectives. Immunol Today 17: 106-108.
25. Remitz A, Reitamo S, (2009) Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 8: 501-506.
26. Periyasamy S, Warrier M, Tillekeratne MPM, Shou W, Sanchez ER, (2007) The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Endocrinol 148: 4716-4726.
27. Klettner A, Herdegen T, (2003) FK506 and its analogs - Therapeutic potential for neurological disorders. Curr Drug Targets CNS Neurol Disord 2: 153-162.
28. Andexer JN, Kendrew SG, Nur-e-Alam M, Lazos O, Foster TA, et al. (2011) Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate. Proc Nat Acad Sci USA 108: 4776-4781.
29. Goranovič D, Kosec G, Mrak P, Fujs S, Horvat J, et al. (2010) Origin of the allyl group in FK506 biosynthesis. J Biol Chem 285: 14292-14300.
30. Mo S, Kim DH, Lee JH, Park JW, Basnet DB, et al. (2011) Biosynthesis of the allylmalonyl-CoA extender unit for the FK506 polyketide synthase proceeds through a dedicated polyketide synthase and facilitates the mutasynthesis of analogs. J Am Chem Soc 133: 976-985.
31. Kosec G, Goranovič D, Mrak P, Fujs S, Kuščer E, et al. (2012) Novel chemobiosynthetic approach for exclusive production of FK506. Metabol Engineer 14: 39-46.
32. Mo S, Yoo YJ, Ban YH, Lee S-K, Kim E, et al. (2012) Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. KCTC 11604BP. Appl Environ Microbiol 78: 2249-2255.
33. Goranovič D, Blažič M, Magdevska V, Horvat J, Kuščer E, et al. (2012) FK506 biosynthesis is regulated by two positive regulatory elements in Streptomyces tsukubaensis. BMC Microbiol 12: 238.
34. Mo S, BanY-H, Park JW, Yoo YJ, Yoon YJ, (2009) Enhanced FK506 production in Streptomyces clavuligerus CKD1119 by engineering the supply of methylmalonyl-CoA precursor. J Ind Microbiol Biotechnol 36: 1473-1482.
35. Chen D, Zhang Q, Zhang Q, Cen P, Xu Z, et al. (2012) Improvement of FK506 production in Streptomyces tsukubaensis by genetic enhancement of the supply of unusual polyketide extender units via utilization of two distinct site-specific recombination systems. Appl Environ Microbiol 78: 5093-5103.
36. Barreiro C, Prieto C, Sola-Landa A, Solera E, Martínez-Castro M, et al. (2012) Draft genome of Streptomyces tsukubaensis NRRL 18488, the producer of the clinically important immunosuppressant tacrolimus (FK506). J Bacteriol 194: 3756-3757.
37. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA (2000) Practical Streptomyces Genetics, 2nd edition,Norwich, UK: John Innes Foundation.
38. Bentley SD, Chater KF, Cerdeño-Tárraga AM, Challis GL, Thomson NR, et al. (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417: 141-147.
39. Gust B, Chandra G, Jakimowicz D, Yuqing T, Bruton CJ, et al. (2004) λ Red-mediated genetic manipulation of antibiotic-producing Streptomyces. Adv Appl Microbiol 54: 107-128.
40. Floriano B, Bibb MJ, (1996) afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2). Mol Microbiol 21: 385-396.
41. Hu H, Zhang Q, Ochi K, (2002) Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase beta subunit) of Streptomyces lividans. J Bacteriol 184: 3984-3991.
42. Shima J, Hesketh A, Okamoto S, Kawamoto S, Ochi K, (1996) Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2). J Bacteriol 178: 7276-7284.
43. Gust B, Challis GL, Fowler K, Kieser T, Chater KF, (2003) PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc Natl Acad Sci USA 100: 1541-1546.
44. Erb A, Luzhetskyy A, Hardter U, Bechthold A, (2009) Cloning and sequencing of the biosynthetic gene cluster for saquayamycin Z and galtamycin B and the elucidation of the assembly of their saccharide chains. ChemBioChem 10: 1392-1401.
45. Polvino W (2012) Reformulations must provide added value: Novel drugs must really improve on the original; dosing convenience alone is not enough. Genetic Engineering and Biotechnology News 32: Feb 15.
46. Turło J, Gajzlerska W, Klimaszewska M, Król M, Dawidowski M, (2012) Enhancement of tacrolimus productivity in Streptomyces tsukubaensis by the use of novel precursors for biosynthesis. Enzyme Microb Technol 51: 388-395.
47. Baltz RH, (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8: 557-563.
48. Nett M, Ikeda H, Moore BS, (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26: 1362-1384.
49. Yin X, Zabriskie TM, (2006) The enduracidin biosynthetic gene cluster from Streptomyces fungicidius. Microbiol 152: 2969-2983.
50. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrewski P, et al. (2011) antiSMASH: Rapid identification, annotation, and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nuc Acids Res 39(suppl 2): W339-W346.
51. Piffaretti J-C, Arini A, Frey J, (1988) pUB307 mobilizes resistance plasmids from Escherichia coli into Neisseria gonorrhoeae. Mol Gen Genet 212: 215-218.
52. Siebenberg S, Bapat PM, Lantz AE, Gust B, Heide L, (2010) Reducing the variability of antibiotic production in Streptomyces by cultivation in 24-square deepwell plates. J Biosci Bioeng 109: 230-234.
53. Bibb MJ, White J, Ward JM, Janssen GR, (1994) The mRNA for the 23S rRNA methylase encoded by the ermE gene of Saccharopolyspora erythraea is translated in the absence of a conventional ribosome-binding site. Mol Microbiol 14: 533-545.
54. Herai S, Hashimoto Y, Higashibata H, Maseda H, Ikeda H, et al. (2004) Hyper-inducible expression system for streptomycetes. Proc Natl Acad Sci USA 101: 14031-14035.